World's Best Scientists 2026 revealed!
British Journal of Clinical Pharmacology
H-index 35

British Journal of Clinical Pharmacology

Ranking & Metrics

Discipline name Position Best Scientists Publications D-Index
Medicine 564 387 507 32

Additional Metrics

Number of Best Scientists*: 589
Documents by Best Scientists*: 655
Top 100 Ranked Scientists*: 12
SCIMAGO H-index: 176
SCIMAGO SJR: 1.155
Impact Factor: 3

Overview

Top Research Topics at British Journal of Clinical Pharmacology?

The journal covers a variety of subjects, including Pharmacology, Internal medicine, Pharmacokinetics, Endocrinology and Anesthesia. While the journal focused on Pharmacology, it was also able to explore topics like Metabolite and Crossover study. British Journal of Clinical Pharmacology explores issues in Internal medicine which can be linked to other research areas like Gastroenterology, Surgery and Cardiology.

While Pharmacokinetics is the focus of British Journal of Clinical Pharmacology, it also provided insights into the studies of Oral administration and Dosing. Excretion and Propranolol are all aspects of Endocrinology research featured in it. It addresses concerns in Anesthesia which are intertwined with other disciplines, such as Placebo and Blood pressure, Heart rate.

British Journal of Clinical Pharmacology focused on Blood pressure research but expanded to cover Hemodynamics.

  • Pharmacology (35.53%)
  • Internal medicine (35.48%)
  • Pharmacokinetics (24.91%)

What are the most cited papers published in the journal?

  • The two-period cross-over clinical trial. (1226 citations)
  • Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications (958 citations)
  • A new taxonomy for describing and defining adherence to medications (876 citations)

Research areas of the most cited articles at British Journal of Clinical Pharmacology:

The main points discussed in the published articles deal with Pharmacology, Internal medicine, Pharmacokinetics, Endocrinology and Anesthesia. The most cited articles explore issues in Internal medicine which can be linked to other research areas like Gastroenterology and Surgery. In addition to Pharmacokinetics research, the journal papers aim to explore topics under Oral administration and Bioavailability.

What topics the last edition of the journal is best known for?

  • Internal medicine
  • Pharmacology
  • Disease

The previous edition focused in particular on these issues:

The journal mainly tackles studies in Internal medicine, Pharmacokinetics, Dosing, Pharmacology and Confidence interval. Some problems in Internal medicine that were presented in it overlapped with concepts under Gastroenterology and Oncology. The studies on Pharmacokinetics discussed can also contribute to research in the domains of Placebo, Tolerability and Urology.

The Dosing study featured in it draws connections with the study of Therapeutic drug monitoring. The Pharmacology works, particularly on Drug are tackled in the journal. Most of the works presented in the journal deals with Confidence interval but it intersects with the subject of Meta-analysis.

The most cited articles from the last journal are:

  • Dosing will be a key success factor in repurposing antivirals for COVID-19. (27 citations)
  • Dose prediction for repurposing nitazoxanide in SARS-CoV-2 treatment or chemoprophylaxis. (17 citations)
  • Pharmacokinetic considerations on the repurposing of ivermectin for treatment of COVID-19. (15 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

The top authors publishing in British Journal of Clinical Pharmacology (based on the number of publications) are:

  • Adam F. Cohen (117 papers) published 8 papers at the last edition, 6 more than at the previous edition,
  • Jeffrey K Aronson (116 papers) published 3 papers at the last edition, 1 less than at the previous edition,
  • James M. Ritter (69 papers) absent at the last edition,
  • Alasdair Breckenridge (67 papers) absent at the last edition,
  • Geoffrey T. Tucker (67 papers) published 1 paper at the last edition the same number as at the previous edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Only papers with recognized affiliations are considered

The top affiliations publishing in British Journal of Clinical Pharmacology (based on the number of publications) are:

  • University of Liverpool (210 papers) published 25 papers at the last edition, 16 more than at the previous edition,
  • French Institute of Health and Medical Research (194 papers) published 27 papers at the last edition, 17 more than at the previous edition,
  • Utrecht University (172 papers) published 17 papers at the last edition, 4 more than at the previous edition,
  • King's College London (147 papers) published 19 papers at the last edition, 11 more than at the previous edition,
  • Pfizer (140 papers) published 2 papers at the last edition, 2 less than at the previous edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 4.49% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 21.67% were posted by at least one author from the top 10 institutions publishing in the journal. Another 12.12% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 12.73% of all publications and 53.48% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

  • Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
  • Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
  • Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
  • Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
  • Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Career paths and requirements for Healthcare and Research Professionals

Understanding the needs and challenges of healthcare and research professionals who closely read and contribute to the British Journal of Clinical Pharmacology is crucial for addressing its varied readership. Many scholars and healthcare professionals seek career advancement or wish to explore specialized areas of their field. For instance, nurse practitioners who are looking to specialize in a wide range of niches, including pharmacology or research, often need guidance on their path towards these advanced roles. Depending on the region, different prerequisites and competencies may be required. For instance, to become a nurse practitioner in New Mexico, certain educational and licensing requirements must be met. These may include a master's or doctoral degree, registered nursing license, nurse practitioner certification, and others. This indicates that the progression from a registered nurse to a nurse practitioner involves substantial dedication, continuing education, and professionalism. For further detailed information about the steps towards becoming a nurse practitioner in New Mexico and what entails the program, you can consult nurse practitioner program requirements new mexico. This guide provides valuable insights into the pathways you can follow to achieve your career goals. In conclusion, healthcare professionals and researchers who contribute to or benefit from the British Journal of Clinical Pharmacology could have varied career paths and specialization interests. Therefore, focusing on career trajectories and professional development needs, like offering credible information and resources, helps in addressing the readership's evolving needs effectively.

Top Publications

  • The Medication Adherence Report Scale: A measurement tool for eliciting patients' reports of nonadherence

    Amy Hai Yan Chan;Rob Horne;Matthew Hankins;Claudia Chisari

    (2020)
    274 Citations
  • Recent developments of HDAC inhibitors: Emerging indications and novel molecules.

    Andrey D. Bondarev;Andrey D. Bondarev;Misty M. Attwood;Jörgen Jonsson;Vladimir N. Chubarev

    (2021)
    220 Citations
  • Hypophosphataemia after treatment of iron deficiency with intravenous ferric carboxymaltose or iron isomaltoside-a systematic review and meta-analysis.

    Benedikt Schaefer;Moritz Tobiasch;André Viveiros;Herbert Tilg

    (2021)
    84 Citations
  • Imatinib, sunitinib and pazopanib : From flat-fixed dosing towards a pharmacokinetically guided personalized dose

    Dpog;Kim Westerdijk;I. M. E. Desar;N. Steeghs

    (2020)
    68 Citations
  • Pharmacovigilance-based drug repurposing: The search for inverse signals via OpenVigil identifies putative drugs against viral respiratory infections.

    Ruwen Böhm;Claudia Bulin;Vicki Waetzig;Ingolf Cascorbi

    (2021)
    65 Citations
  • Advances and roadblocks in the treatment of malaria

    Borimas Hanboonkunupakarn;Nicholas J. White;Nicholas J. White

    (2020)
    62 Citations
  • Dose prediction for repurposing nitazoxanide in SARS-CoV-2 treatment or chemoprophylaxis.

    Rajith K. R. Rajoli;Henry Pertinez;Usman Arshad;Helen Box

    (2021)
    58 Citations
  • TDM is dead. Long live TCI

    Nick Holford;Guangda Ma;David Metz

    (2020)
    57 Citations
  • Phase I study of imalumab (BAX69), a fully human recombinant antioxidized macrophage migration inhibitory factor antibody in advanced solid tumours.

    Devalingam Mahalingam;Devalingam Mahalingam;Manish R. Patel;Jasgit C. Sachdev;Lowell L. Hart

    (2020)
    55 Citations
  • Warfarin dosing algorithms: A systematic review.

    Innocent G. Asiimwe;Eunice J. Zhang;Rostam Osanlou;Andrea L. Jorgensen

    (2021)
    54 Citations

Related Online Degrees & Career Pathways

For those interested in studying Medicine in the USA, exploring related online degrees can open diverse career opportunities in healthcare. Fields such as health information management, nutrition, sonography, and radiology complement medical knowledge and offer practical skill sets that are in high demand.

For example, a health information management online degree prepares students to manage healthcare data efficiently, supporting patient care through accurate documentation and technology.

Similarly, an online nutrition masters program focuses on the science of diet and wellness, helping professionals guide patients in improving health outcomes through nutrition.

For those interested in diagnostic imaging, sonography programs online offer a pathway to become skilled ultrasound technicians, a vital role in medical diagnostics.

Additionally, pursuing online radiology programs can lead to careers as radiologic technologists, professionals who perform imaging examinations critical to patient diagnosis and treatment.

These online degrees provide flexible, affordable options for expanding your expertise and advancing your career in the evolving healthcare landscape.

Best Scientists Contributing to This Journal

Recently Published Articles